 WON-SALEM, N.C., Sept. 23, 2022 GLOBE NEWSWIRE -- ProKidney Corp. Nasdaq: PROK ProKidney, a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease CKD, today announced that Dr. Tim Bertram, Chief Executive Officer of ProKidney, will present a corporate overview at the Jefferies Cell and Genetic Medicine Summit at 1:30 p.m. ET on Thursday, September 29, 2022, in New York, NY. 